Determining Molecular Mechanisms of Chikungunya Virulence and Attenuation
Determining Molecular Mechanisms of Chikungunya Virulence and Attenuation
批准号:
7897893
负责人:
KATHERINE D RYMAN
金额:
$18.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-22 至 2012-06-30
关键词:
AcuteAcute DiseaseAdultAfricanAgeAlphavirusAnimal ModelAntiviral AgentsArbovirusesAreaArthralgiaArthritisArthropodsAsian AmericansAttenuatedBiological WarfareBioterrorismBiteBlood Chemical AnalysisBlood VesselsCanadaCategoriesCellsCessation of lifeChikungunya virusChildComplementary DNACulicidaeDengueDevelopmentDiagnosisDiseaseDisease OutbreaksDisseminated Intravascular CoagulationEmerging Communicable DiseasesEpidemicEtiologyEuropeFamilyFebrile ConvulsionsFeverGoalsHumanIFNAR1 geneImmune responseIndiaIndian Ocean IslandsInfectionInflammatoryInflammatory InfiltrateInterferon Type IInterferonsIslandJointsKnowledgeLicensingLifeMadagascarMauritiusMeasuresModelingMolecularMosquito-borne infectious diseaseMusMuscleMutationMyositisNeurologicNewborn AnimalsPathogenesisPathologyPolyarthritidesPopulationPopulations at RiskProcessResearchRodentRoleRoss river virusSenegalSeverity of illnessSeychellesSindbis VirusSiteSupportive careSymptomsSystemic diseaseTestingTherapeuticTherapeutic InterventionTissuesTogaviridaeUnited StatesVaccinesVariantVascular DiseasesVirulenceVirulentVirusVirus DiseasesVirus Replicationage relatedattenuationbasebiodefensechemokinechikungunyacomparativecytokinedesigndisease phenotypeeffective therapyhuman diseaseimprovedin vivomembermouse modelmutantnonhuman primatepandemic diseasepathogenreceptorresponsesubcutaneoustherapeutic vaccinetransmission processvaccine candidatevector mosquitovirus host interactionvirus pathogenesisvirus tropism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Alphavirus genus, family Togaviridae, includes viruses that are significant human pathogens. Chikungunya virus (CHIKV) is an arbovirus, transmitted between human and non-human primates by the bite of an infected mosquito vector. CHIKV periodically causes explosive epidemics in naive human populations in the African, Asian and American tropics. Since early 2005, a CHIKV epidemic has been responsible for over 1.5 million cases of CHIK fever in India and the Indian Ocean islands of Riunion, Mauritius, Madagascar and Seychelles. Furthermore, travelers returning to Europe, Canada and the United States from these areas have been diagnosed with the disease raising the possibility for outbreaks in other parts of the world. CHIK fever is rarely fatal, although the current epidemic is causing a higher than typical death toll. In adults, the infection resembles dengue fever, with acute febrile illness associated with excruciating muscle and joint pain. The symptoms of arthralgia/arthritis frequently persist for weeks or months later the initial illness has disappeared. However, the severity of disease is strongly age-dependent: infected children rarely develop arthritis, but commonly suffer febrile convulsions with possible associated neurologic sequelae and hemorrhagic manifestations. Although CHIKV causes severe human disease on an epidemic/pandemic scale, the pathogenesis of the virus remains largely uncharacterized, no licensed vaccine is available and the treatment of human infections is limited to supportive care.
The objective of the proposed research is to provide an understanding of the mechanisms of virus/host interaction and thereby facilitate the subsequent design of therapeutics for the treatment of acute disease and vaccines for protection. These studies will be facilitated by the development of a genetically-defined pathogenesis model for CHIK, including a cDNA clone of two natural CHIKV isolates: the CHIKV-37997 strain isolated during an epidemic in Senegal, 1983 and the La Rhunion (CHIKV-LR) strain isolated on Riunion Island early in the current epidemic. We propose to develop murine pathogenesis models that accurately reproduce the etiologies of human CHIKV infection, both hemorrhagic and arthritogenic, by exploring virus virulence and host response. The specific aims of the application are: 1) To characterize the febrile response and hemorrhagic manifestations in fatal infection of suckling mice versus self-limiting disease in adults; 2) To characterize arthritogenic manifestations of CHIKV infection in non-fatal disease of older mice; and 3) To improve murine pathogenesis models by mouse-adaptation of CHIKV. We hypothesize that comparison of fatal to non-fatal infections will identify host- and virus-encoded determinants of disease severity. These determinants will provide targets for therapeutic intervention during acute infection, whether acquired from natural arthropod transmission or a biowarfare/bioterrorism attack.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IVIS Spectrum CT Imaging System in BSL-3 Containment
-
批准号:8447769
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2013
-
负责人:KATHERINE D RYMAN
-
依托单位:
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine
-
批准号:8262675
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2011
-
负责人:KATHERINE D RYMAN
-
依托单位:
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine
-
批准号:8183819
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2011
-
负责人:KATHERINE D RYMAN
-
依托单位:
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine
-
批准号:8501251
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2011
-
负责人:KATHERINE D RYMAN
-
依托单位:
A Small Animal Model for Viscerotropic Disease to Improve Yellow Fever Vaccine
-
批准号:8692632
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2011
-
负责人:KATHERINE D RYMAN
-
依托单位:
Elucidating molecular mechanisms of yellow fever virus virulence
-
批准号:8067087
-
项目类别:
-
资助金额:$22.42万
-
财政年份:2010
-
负责人:KATHERINE D RYMAN
-
依托单位:
Elucidating molecular mechanisms of yellow fever virus virulence
-
批准号:7896372
-
项目类别:
-
资助金额:$20.18万
-
财政年份:2010
-
负责人:KATHERINE D RYMAN
-
依托单位:
Determining Molecular Mechanisms of Chikungunya Virulence and Attenuation
-
批准号:7996732
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2009
-
负责人:KATHERINE D RYMAN
-
依托单位:
Rational design & optimization of new live-attenuated vaccines for alphaviral enc
-
批准号:7649158
-
项目类别:
-
资助金额:$16.52万
-
财政年份:2008
-
负责人:KATHERINE D RYMAN
-
依托单位:
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS
-
批准号:7720565
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2008
-
负责人:KATHERINE D RYMAN
-
依托单位:
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS
-
批准号:7610513
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2007
-
负责人:KATHERINE D RYMAN
-
依托单位:
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS
-
批准号:7381980
-
项目类别:
-
资助金额:$28.56万
-
财政年份:2006
-
负责人:KATHERINE D RYMAN
-
依托单位:
Innate immune evasion and/or antagonism by eastern equine encephalitis virus
-
批准号:7082476
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2006
-
负责人:KATHERINE D RYMAN
-
依托单位:
Innate immune evasion and/or antagonism by eastern equine encephalitis virus
-
批准号:7230127
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2006
-
负责人:KATHERINE D RYMAN
-
依托单位:
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS
-
批准号:7171199
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2005
-
负责人:KATHERINE D RYMAN
-
依托单位:
LSUHSC COBRE: ROLE OF INNATE IMMUNITY IN YELLOW FEVER VIRUS PATHOGENESIS
-
批准号:6981873
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2004
-
负责人:KATHERINE D RYMAN
-
依托单位:
Identifying Factors Limiting CHIKV Disease by Global Transcriptional Profiling
-
批准号:8434296
-
项目类别:
-
资助金额:$50.57万
-
财政年份:--
-
负责人:KATHERINE D RYMAN
-
依托单位:
Identifying Factors Limiting CHIKV Disease by Global Transcriptional Profiling
-
批准号:8436330
-
项目类别:
-
资助金额:$46.93万
-
财政年份:--
-
负责人:KATHERINE D RYMAN
-
依托单位:
海外基金